https://medsparadar.com daily 1 https://medsparadar.com/feed daily 0.9 https://medsparadar.com/impact weekly 0.7 https://medsparadar.com/privacy yearly 0.2 https://medsparadar.com/terms yearly 0.2 https://medsparadar.com/alerts/fda-federal-register-notice-list-of-bulk-drug-substances-for-which-there-is-a-cl-31721222-98fd-4191-8f0e-616719510e0f 2026-06-26 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-lidocaine-china-ae197f99-62b8-4f4c-adc7-4d97d0cefe66 2026-06-26 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-implant-dermal-collagen-for-aesthetic-use-south-korea-2a3c00a5-faca-4951-8182-3577f3b1b015 2026-06-26 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-semaglutide-anti-diabetic-india-b80d1c19-c6ac-4171-81d2-778f3846efe4 2026-06-26 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-implant-dermal-collagen-for-aesthetic-use-south-korea-4640ca78-2a4b-4708-8334-e6298134ac31 2026-06-26 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-triamcinolone-glucocorticoid-guatemala-de61e154-242c-45ec-b4d0-0bbf2865718a 2026-06-24 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-lidocaine-hcl-anesthetic-south-korea-e2dc74e4-0e5a-4559-b0be-4f3293f738bb 2026-06-24 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-tirzepatide-anti-diabetic-bangladesh-481b1c08-35df-4403-b51f-b77c8232b69a 2026-06-23 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-onabotulinumtoxina-south-korea-38257fd8-c2ac-492e-9bab-cec7fb3708b7 2026-06-23 monthly 0.6 https://medsparadar.com/alerts/fda-warning-letter-ketaminelab-org-drugs-a21d2cb5-409b-431d-a398-ce1bd40f0299 2026-06-23 monthly 0.6 https://medsparadar.com/alerts/fda-import-refusal-semaglutide-anti-diabetic-united-states-3bc216ab-9539-4e5a-89d7-e587927e2e2b 2026-06-22 monthly 0.6 https://medsparadar.com/alerts/ftc-files-contempt-motion-against-amare-global-and-three-individuals-over-unsubs-b9ae21d3-3f5e-43c9-8b5b-68532d2b6592 2026-06-12 monthly 0.6 https://medsparadar.com/alerts/fda-shortage-liraglutide-injection-injection-current-4b49a9bc-b227-4995-9da1-bbd042ab69be 2026-06-11 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-liraglutide-injection-18-mg-3-ml-6-mg-ml-rx-only-manufacture-8e76c19c-6698-40d4-8296-572b3d9e148c 2026-05-27 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-agency-information-collection-activities-proposed-co-f4d20615-415b-4c8e-a629-f15e99140c72 2026-05-26 monthly 0.6 https://medsparadar.com/alerts/ma-ma-h5455-regulating-the-operation-of-medical-spas-525fdd93-3315-496d-b909-f78c2dcbcb8c 2026-05-26 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-element-materials-technology-boston-acton-inc-4-observa-218febe9-35ea-4241-9020-6c79cfa4b21a 2026-05-04 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-list-of-bulk-drug-substances-for-which-there-is-a-cl-0e6609be-e3d0-457c-8c37-b2fb41432e10 2026-05-01 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-determination-that-ozempic-semaglutide-solution-2-mi-b3ef96a0-0c49-4d95-9cf9-f5ff0bb8f800 2026-04-30 monthly 0.6 https://medsparadar.com/alerts/co-co-sb130-medical-spas-deceptive-trade-practices-248245c4-1b6e-4519-bc87-86086cd861dd 2026-04-23 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-glycine-cyanocobalamin-injectable-2-5-mg-5-mg-1-6fcc1fba-c287-446a-b990-1d6cf0c0ee04 2026-04-22 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-preye-llc-4-observations-dbcc3fe3-8851-4558-a7de-e95978d61f94 2026-03-19 monthly 0.6 https://medsparadar.com/alerts/fl-fl-h1429-licensure-of-medical-spas-85ec4540-5724-4175-9acf-97290017a419 2026-03-13 monthly 0.6 https://medsparadar.com/alerts/fl-fl-s1728-licensure-of-medical-spas-e917f33e-a4b7-4da6-91d2-cb24c9cb20f3 2026-03-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-for-rx-compounding-use-only-packaged-in-a-1g-ndc-709a3035-8098-4700-b445-82001d218c10 2026-03-11 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-inj-2-mg-x-5-sterile-multi-dose-vial-rx-only-nom-02a87674-9d3c-4329-a568-e9cd62ebd067 2026-03-11 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-inj-2mg-x-10-sterile-multi-dose-vial-rx-only-nom-c76da5dc-28c1-469c-a389-a07c37d387e5 2026-03-11 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-for-rx-compounding-use-only-packaged-in-a-1g-ndc-244322ca-e774-40c1-8f7b-0def8b422ac3 2026-03-11 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-inj-15mg-x-4-sterile-multi-dose-vial-rx-only-nom-fafbb3f3-7596-45db-ab00-e43cdfb74209 2026-03-11 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-inj-10mg-sterile-multi-dose-vial-rx-only-nomida-01bf0eb7-f01b-4bde-ac7b-d544d22134a0 2026-03-11 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-pharmaceutics-international-inc-9-observations-b384a1a8-bff0-4033-a08a-ff058f5c6e79 2026-03-06 monthly 0.6 https://medsparadar.com/alerts/in-in-sb0282-compounding-drugs-registration-of-medical-spas-73cfe0f8-0096-471b-9607-cbf491dab91a 2026-03-05 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-sharp-sterile-manufacturing-llc-6-observations-960531e2-ccd2-4f61-8846-30c1e8bc59b5 2026-03-05 monthly 0.6 https://medsparadar.com/alerts/in-in-hb1358-indiana-department-of-health-2617b9b8-3445-449d-bb0b-1a9df2653d37 2026-03-04 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-gallant-pet-inc-10-observations-8d7eda01-6f12-476d-9eab-793e208ad00a 2026-02-27 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-gasco-industrial-corp-13-observations-0b926476-05ef-447b-b057-71f070d10bda 2026-02-27 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-tan-alize-kozmetik-ve-temizlik-urunleri-sanayi-ve-ticar-3fc9ed9c-d2d9-41f5-aac7-eaf40ec738bb 2026-02-27 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-corerx-inc-7-observations-0d736782-a763-4ec9-839c-7edef77ca711 2026-02-26 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-agency-information-collection-activities-submission-f1c9b58a-53ba-4c4c-afbb-5ea9fa5e7f3f 2026-02-23 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-gilead-sciences-inc-7-observations-049606eb-4b01-4303-923b-bdb3c9cfb794 2026-02-18 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-k-c-pharmaceuticals-inc-13-observations-a6c5ba68-959c-4779-9c24-a48679d3ed57 2026-02-13 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-tropical-seas-inc-8-observations-c6424f95-090d-47f3-b2fb-f31caded004e 2026-02-12 monthly 0.6 https://medsparadar.com/alerts/az-az-hb4047-medical-spas-licensure-regulation-f1f31960-a7db-4ace-b155-e711e196ea39 2026-02-10 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-alcami-carolinas-corporation-6-observations-4da4f3b3-0273-4281-bca7-880f635ab455 2026-02-06 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-eugia-pharma-specialities-limited-11-observations-6ab0b20c-4fd3-4121-95ae-b7a50ab94cf8 2026-02-06 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-nice-pak-products-llc-4-observations-9ef99e7f-acdc-4bf5-b174-3bb93e3bfc30 2026-02-05 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-ony-biotech-inc-3-observations-f796a0a4-6091-46b7-bbf6-fad06538d32f 2026-02-05 monthly 0.6 https://medsparadar.com/alerts/ms-ms-sb2544-mississippi-active-pharmaceutical-ingredient-quality-assurance-act-18a6ea6e-ac63-4bc0-90b5-3bbac9eb983f 2026-02-03 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-iso-tex-diagnostics-inc-5-observations-31627270-e31a-48be-b328-40e761c352ea 2026-02-03 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-element-materials-technology-oakland-concord-6-observat-9d53976a-ebb3-4a46-a929-c274e2cd910a 2026-01-30 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-hibrow-healthcare-private-limited-2-observations-b576ccd0-e20d-4063-9660-2d8ee60d5e3b 2026-01-30 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-american-regent-inc-4-observations-e6b0e782-37e8-4c08-80f4-0d6545981083 2026-01-29 monthly 0.6 https://medsparadar.com/alerts/fda-device-recall-class-ii-brand-name-leaseir-product-name-leaseir-mhr-xcell-mod-f9190a7d-b783-4b5d-986a-c604421437c3 2026-01-28 monthly 0.6 https://medsparadar.com/alerts/ma-ma-h5087-regulating-the-operation-of-medical-spas-8dca079f-3775-4632-ad2e-bea7b11a9194 2026-01-27 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-anika-therapeutics-inc-4-observations-a823527c-4de9-4a1f-a330-21d8aa4d7e83 2026-01-22 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-excel-vision-11-observations-636e4465-d9d2-4fc6-a0c6-7f622fa28309 2026-01-22 monthly 0.6 https://medsparadar.com/alerts/ia-ia-hsb591-a-bill-for-an-act-establishing-the-medical-spa-oversight-act-and-ma-5b339170-b482-4dcd-8af2-73aaf86738c1 2026-01-20 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-oneblood-inc-1-observation-7bec6aed-92af-44cd-a97b-b56dd0b0cba7 2026-01-09 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-south-bend-medical-foundation-inc-1-observation-3ab62ff6-cc1d-421c-bbcc-3809a8ba6045 2026-01-07 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-wegovy-semaglutide-injection-1-mg-0-5-ml-4-single-dose-prefi-e4b0907c-5a22-406a-9c07-92a01e93d450 2026-01-07 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-wegovy-semaglutide-injection-0-5-mg-0-5-ml-4-single-dose-pre-5d12ad29-1ff8-4ec6-a461-fe88e506a192 2026-01-07 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-blaine-labs-inc-12-observations-a4d3399f-b24b-4e66-b5ff-c58628983ebe 2025-12-22 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-international-medication-systems-ltd-8-observations-fb074a8c-8cf5-485b-a6fa-b8ef13344459 2025-12-19 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-wyeth-pharmaceutical-division-of-wyeth-holdings-llc-4-o-481e0043-370a-49ca-92a1-7a6231069054 2025-12-17 monthly 0.6 https://medsparadar.com/alerts/pa-pa-hb1881-further-providing-for-pharmacy-technician-and-pharmacy-technician-t-feeadbaa-2510-468a-863c-a627ed0f4fbf 2025-12-16 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-life-science-outsourcing-inc-5-observations-3add75cd-dc90-4a34-95f6-6b839bdb29fc 2025-12-11 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-denver-solutions-llc-7-observations-2d45ab97-0079-400d-a05d-6a214b56d5ed 2025-12-11 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-medtronic-inc-2-observations-e67e4efc-8da2-4e9e-8306-441f12d1f0b0 2025-12-10 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-piramal-pharma-solutions-inc-4-observations-55e6edd7-5b9f-4a0c-90b8-c6aebbce8765 2025-12-10 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-biomat-usa-inc-4-observations-d7869dd8-a936-4eab-a5dc-15158054f9cf 2025-12-09 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-ecolab-llc-2-observations-780029ea-243e-4824-96af-9251b7efa4b4 2025-12-05 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-st-marys-medical-park-pharmacy-7-observations-6382b786-5b73-4af6-a4d1-9a51e6c02195 2025-12-04 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-agency-information-collection-activities-proposed-co-9c152f70-5b25-401d-9dc3-587e7c4f027a 2025-11-24 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-eagle-analytical-services-inc-4-observations-6397d207-9c06-482c-8bd4-b11f01d7b581 2025-11-21 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-sato-pharmaceutical-co-ltd-10-observations-3a1cc2dc-f12a-4b40-a6f3-bcc1dc5eaffd 2025-11-21 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-fordoz-pharma-co-9-observations-5fd0c85d-ebd4-4718-80e9-eeb83a76c45b 2025-11-12 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-alliance-medical-products-inc-4-observations-ec49da22-35f2-4634-aed8-b82b945bc8e8 2025-11-07 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-injection-10-mg-4-ml-2-5-mg-ml-4ml-multidose-via-1336b892-7a09-45b9-8483-000316067fce 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-injection-6mg-2-4ml-2-5-mg-ml-2-4ml-multidose-vi-8e88a0b9-671f-4d85-bee1-ced522dcfd4d 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-injection-2-5mg-1ml-2-5-mg-ml-1ml-multidose-vial-334d0331-4e94-4fe9-b96b-5124c904c725 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-injection-8mg-3-2ml-2-5-mg-ml-3-2ml-multidose-vi-40134bde-0201-4bf9-81ee-94772ae2c4f8 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-injection-12-5-5ml-2-5-mg-ml-5ml-multidose-vial-b759dd11-0095-4370-8dcf-a08389a278f5 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-injection-5-mg-2-ml-2-5-mg-ml-2ml-multidose-vial-6790f4c6-e198-4cf0-ac29-303fb666b427 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-injection-27-mg-3-ml-9-mg-ml-3ml-multidose-vial-3f29989a-5235-49b7-9b08-dadeeee6c2fc 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-fresenius-kabi-compounding-llc-7-observations-8deee1c7-534b-40af-874f-bf22e4f01378 2025-11-05 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-grand-river-aseptic-manufacturing-inc-2-observations-ee9db02b-7cd0-44c2-b735-49c66e2889a2 2025-11-04 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-jubilant-hollisterstier-general-partnership-9-observati-d097ed81-7342-4955-ae46-cbf1465fca0b 2025-11-03 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-par-health-usa-llc-4-observations-6d531059-dfd0-4cc8-ab99-03712b6d653c 2025-10-20 monthly 0.6 https://medsparadar.com/alerts/pa-pa-sb1055-further-providing-for-pharmacy-technician-and-pharmacy-technician-t-30194867-b3e5-453d-8054-7047f1e70480 2025-10-17 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-for-injection-a-20-mg-b-20-mg-ml-10-ml-multi-dos-09a7d4eb-5ddd-4ca2-b402-e56aad67239a 2025-10-15 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-with-b12-for-injection-all-strengths-and-present-d2563820-b2da-464b-bce9-f478bfcad284 2025-10-15 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-60mg-10-ml-for-injection-10ml-vial-lyophilized-a-02d1f232-ef4c-4195-b5ed-85e44b43c65f 2025-10-15 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-alcami-carolinas-corporation-3-observations-e60eb28d-8598-4fa2-b77b-81d4a862148e 2025-09-26 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-actavis-laboratories-ut-inc-4-observations-04f50aa0-af6f-4287-b9cc-c1025064a6fb 2025-09-19 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-barbara-ann-karmanos-cancer-hospital-3-observations-77ff39fb-4f75-483d-b496-3e8d1706d2db 2025-09-19 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-2-5-mg-ml-injection-0-8-ml-boothwyn-pharmacy-954c109b-2d70-4e74-a525-479fdeb2d559 2025-09-10 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-2-5-mg-ml-injection-2-ml-boothwyn-pharmacy-a30b6d64-275d-499e-92ac-28fea6fa99d8 2025-09-10 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-2-5-mg-ml-injection-4-ml-boothwyn-pharmacy-4905c07b-9d40-4844-90bc-c8a8a149c9f7 2025-09-10 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-north-american-custom-laboratories-llc-dba-farmakeio-su-789ec44b-d141-42bf-9155-59a1e5ebe4b0 2025-09-05 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-bio-medical-pharmaceutical-manufacturing-corporation-9-9c56c8dc-5c3c-42aa-b8e6-114316eb8109 2025-08-29 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-nephron-sc-llc-6-observations-441a9bcf-b634-405e-9111-62f469c1bef2 2025-08-22 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-lonza-tampa-llc-9-observations-23bc7e48-f433-4461-8c0f-f7e8d2bca83d 2025-08-22 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-united-laboratories-manufacturing-llc-8-observations-c3c93a9a-8bad-44cc-814d-2df275a6dce6 2025-08-15 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-cyanocobalamin-1-5-mg-0-25mg-0-5-ml-inj-sol-inje-6a7d4e1f-0efa-4ca9-b67a-33c516545d91 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-cyanocobalamin-injection-solution-2-21-mg-0-25mg-d15af712-9c8f-4b7f-915b-aaa8f5986778 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-cyanocobalamin-0-88-mg-0-25mg-0-5-ml-inj-sol-inj-e7ea09b5-b009-4455-9fb3-320c2c13632b 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-cyanocobalamin-0-22-mg-0-25mg-0-5-ml-inj-sol-inj-7deb6d88-38b6-49dc-ab39-847e404f7b2d 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-cyanocobalamin-0-44-mg-0-25mg-0-5-ml-inj-sol-inj-81f9daeb-d6a3-48e0-81a3-2a2d70314ce8 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-cyanocobalamin-2-67-mg-0-25mg-0-5-ml-inj-sol-inj-94a2f798-fbca-4c82-8dbf-8dcd0e4a5720 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-niacinamide-4-4-mg-1-0mg-0-5-ml-inj-sol-inject-0-afa63a26-eb49-4384-9e4f-e7ad68dcaac5 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-niacinamide-2-2-mg-1-0mg-0-5-ml-inj-sol-inject-0-2a453762-eb21-484e-8f5c-3144dac573bc 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-niacinamide-11-24-mg-1-0mg-0-5-ml-inj-sol-inject-cc859745-340f-42f5-ada4-508da9c57f33 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-niacinamide-16-6-mg-1-0mg-0-5-ml-inj-sol-inject-8211fe96-16a1-4487-ba8a-a9cc0ce95324 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-niacinamide-6-6-mg-1-0mg-0-5-ml-inj-sol-inject-0-836a2c4f-3917-4e78-b7b5-abf60ee5852f 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-niacinamide-8-8-mg-1-0mg-0-5-ml-inj-sol-inject-0-99fe9d1c-352c-4a10-98a4-1d2c6a74fd3d 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-niacinamide-13-2-mg-1-0mg-0-5-ml-inj-sol-inject-c7b6bdc2-e1a0-4664-a2a4-69ee27e1dc88 2025-08-13 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-fareva-morton-grove-inc-7-observations-0896cde6-f28c-4037-b0f6-49c56b4662fd 2025-08-12 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-steri-pharma-llc-3-observations-21eac366-2fa1-41be-b014-d43df7daf0cf 2025-08-08 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-cardinal-health-414-llc-5-observations-f4896ca9-3851-48f8-ab43-1e8c2a6958d2 2025-07-31 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-telix-isotherapeutics-group-inc-10-observations-00ef3a38-db25-47ae-b395-021bdc624803 2025-07-31 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-outsourcing-facility-fee-rates-for-fiscal-year-2026-0dbbc4d5-b8c0-4d85-bf14-48d0d1bca7c1 2025-07-30 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-doh-central-pharmacy-6-observations-9c7a7c6e-97e1-454a-a891-682b0cea2eef 2025-07-28 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-north-american-science-associates-llc-1-observation-4b416942-6381-41a5-84e5-d7be42eee82d 2025-07-24 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-right-value-drug-stores-llc-5-observations-49af8185-0828-4492-8b92-3756c1bd0cdd 2025-07-18 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-bso-llc-9-observations-85e16267-6a0b-4606-82cc-480c69804f6a 2025-07-16 monthly 0.6 https://medsparadar.com/alerts/fda-inspection-citations-biomat-holdings-mount-vernon-newark-1-observation-ae1fe921-dd4b-4e6b-9d39-165be4d4e534 2025-07-15 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-5-mg-ml-pre-filled-syringe-thrive-health-solutio-1d4f2a79-a550-4f0c-afa4-f1df8bb92a87 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-2-5-mg-ml-pre-filled-syringe-thrive-health-solut-28062387-5c9f-4f78-ad1b-53e640734d57 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-semaglutide-cyanocobalamin-injectable-5mg-1mg-ml-pre-filled-c9b62d2f-ea47-4445-ab7e-450dfe490a27 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-injections-30mg-ml-pre-filled-syringe-thrive-hea-036b3b9f-36d4-41ee-b6a1-debecda8f6f4 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-cyanocobalamin-injectable-15mg-1mg-ml-pre-filled-8c7d907f-ad7a-4a7a-a40c-b57782d6afac 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-injections-10mg-ml-pre-filled-syringe-thrive-hea-de9bb2da-735f-47ed-b70b-b6fe88083193 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-cyanocobalamin-injectable-30mg-1mg-ml-15mg-0-5mg-609ecab2-34ad-434d-80dd-bdab2eb2490c 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-tirzepatide-injections-20mg-ml-pre-filled-syringe-thrive-hea-dbf65e68-0c96-4d7c-9f8e-ce6d199c1bfa 2025-07-02 monthly 0.6 https://medsparadar.com/alerts/ri-ri-h5351-mandates-cosmetic-medical-procedures-be-performed-by-a-physician-pa-faec5cd9-d695-404a-abcd-f8a3cba3891b 2025-06-30 monthly 0.6 https://medsparadar.com/alerts/ri-ri-s0976-mandates-cosmetic-medical-procedures-be-performed-by-a-physician-pa-8a2f533e-82cf-4aa3-983b-8e99f9be96a0 2025-06-30 monthly 0.6 https://medsparadar.com/alerts/fda-recall-class-ii-wegovy-semaglutide-injection-2-4-mg-0-75-ml-4-single-dose-pr-22f4ca96-6a97-4b0b-8108-ce633e13fe97 2025-05-07 monthly 0.6 https://medsparadar.com/alerts/co-co-hb1024-medical-aesthetic-services-delegation-disclosures-20961fa7-edec-4913-86ba-8154ed4bcc65 2025-04-07 monthly 0.6 https://medsparadar.com/alerts/ms-ms-hb1430-prescription-drugs-prohibit-licensing-boards-from-prohibiting-pract-1d60d53e-2ca2-4f61-bc6f-673121acd0b1 2025-02-13 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-interim-policy-on-compounding-using-bulk-drug-substa-f4d93a6e-7722-4a49-a38f-9168aaf56b8c 2025-01-07 monthly 0.6 https://medsparadar.com/alerts/fda-federal-register-notice-interim-policy-on-compounding-using-bulk-drug-substa-0bf40ee4-c2bd-4b34-b5d3-32d1e9cef99f 2025-01-07 monthly 0.6 https://medsparadar.com/alerts/il-il-hb4281-certified-medical-esthetician-acce0481-50fa-43c4-bb6f-ff4fd6010ce1 2025-01-07 monthly 0.6 https://medsparadar.com/alerts/ct-ct-hb05236-an-act-concerning-recommendations-by-the-department-of-consumer-pr-763bd9b0-992f-491b-89e5-7f37904aee33 2024-06-06 monthly 0.6 https://medsparadar.com/alerts/ri-ri-h8296-provides-that-the-performance-of-cosmetic-medical-services-is-the-pr-a0e8db55-079c-4f9e-9352-0741be6c0b28 2024-05-22 monthly 0.6 https://medsparadar.com/alerts/ri-ri-s2870-provides-that-the-performance-of-cosmetic-medical-services-is-the-pr-0d2765a7-fe98-43cb-ab62-a0096648cd39 2024-03-22 monthly 0.6 https://medsparadar.com/alerts/ri-ri-h7820-provides-that-licensed-health-care-facilities-be-prohibited-from-usi-9049d082-8ed8-43ff-be31-c70afc437d63 2024-03-01 monthly 0.6 https://medsparadar.com/alerts/sc-sc-h4084-dental-administration-of-neuromodulators-1483bce6-5f4c-4008-a4d6-548bfcc9e26a 2023-03-07 monthly 0.6 https://medsparadar.com/alerts/nh-nh-hb105-relative-to-the-registration-of-medical-spas-5b1dd9cb-1a12-43e8-bcef-410917b4f7d3 2022-12-23 monthly 0.6 https://medsparadar.com/alerts/tn-tn-hb0915-an-act-to-amend-tennessee-code-annotated-section-62-4-109-relative-321e2637-64af-449c-964e-5a6b87b4dbff 2021-05-18 monthly 0.6 https://medsparadar.com/alerts/tn-tn-sb1339-an-act-to-amend-tennessee-code-annotated-section-62-4-109-relative-b2c2139e-a154-4770-bb59-a3766caa495b 2021-05-18 monthly 0.6